Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2553 (LINC02553) is a human long non-coding RNA (lncRNA) gene, which means it is a non-protein-coding transcript that resides in intergenic regions of the genome and serves as part of the non-coding transcriptome[1][3][5][7][9][11]. LINC02553 is annotated in genome resources such as Ensembl (ENSG00000255039) and recognized by the HGNC (HGNC:53588)[7][5][9]. Its precise biological function and disease relevance are currently not well characterized in the scientific literature, and there are no established drug interactions, disease roles, or mechanisms of action attributed to this lncRNA as of the latest available data[11]. It is not considered a canonical therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2553 (LINC02553).